Analgesic and antiinflammatory effects of two novel kappa-opioid peptides.
about
Novel κ-opioid receptor agonist MB-1C-OH produces potent analgesia with less depression and sedationThe mu opioid agonist morphine modulates potentiation of capsaicin-evoked TRPV1 responses through a cyclic AMP-dependent protein kinase A pathwayWill peripherally restricted kappa-opioid receptor agonists (pKORAs) relieve pain with less opioid adverse effects and abuse potential?Peptide kappa opioid receptor ligands: potential for drug development.The role of kappa-opioid receptor activation in mediating antinociception and addiction.Peripheral kappa-opioid agonists for visceral pain.Sex differences in opioid analgesia: clinical and experimental findings.Kappa Opioid Receptor-Mediated Disruption of Novel Object Recognition: Relevance for Psychostimulant Treatment.Opioids and opiates: analgesia with cardiovascular, haemodynamic and immune implications in critical illness.Gene therapy for pancreatitis pain.Opioids for the treatment of arthritis pain.Behavioral Characterization of κ Opioid Receptor Agonist Spiradoline and Cannabinoid Receptor Agonist CP55940 Mixtures in Rats.Endogenous opioid analgesia in peripheral tissues and the clinical implications for pain control.Peripheral neurobiologic mechanisms of antiallodynic effect of warm water immersion therapy on persistent inflammatory pain.Chemical analgesia for velvet antler removal in deer.Treatment of inflamed pancreas with enkephalin encoding HSV-1 recombinant vector reduces inflammatory damage and behavioral sequelae.The effects of acute restraint stress on nociceptive responses evoked by the injection of formalin into the temporomandibular joint of female rats.Enkephalin-encoding herpes simplex virus-1 decreases inflammation and hotplate sensitivity in a chronic pancreatitis model.A population pharmacokinetic and pharmacodynamic study of a peripheral κ-opioid receptor agonist CR665 and oxycodone.The analgesic and anti-inflammatory effects of Salvinorin A analogue β-tetrahydropyran Salvinorin B in mice.
P2860
Q28259561-4566AA77-C823-453E-8226-1B8A899E26D0Q28768058-CA0E0EC7-AD39-49C6-B498-C33AA9D86CD2Q30250027-521CCF56-B544-4ACF-843D-E8D030BEA247Q33442900-FECAB9ED-CF42-44F1-BA5E-C93AEAFC63BBQ34132638-DC96E39D-142D-4209-9F97-4DE4197FEC11Q35722680-5BD0E3D4-B9A2-4B5E-8449-0D2893DA6217Q35868750-3870652A-A78E-4CED-A4AE-9053C7F51F32Q36163631-0DF2797A-8B86-44FD-BC12-AA8A6EAF362DQ36371673-C9326CF4-4B0C-4602-ACE0-3EDB956E6A94Q37406982-8FD7707C-C90A-4915-87E7-EE29691D2D98Q38166805-92922C7D-6D74-44FB-8483-C73980E6C4C4Q39141647-D4A4EBDD-BC22-4A97-AC37-C7D7AD2E96DCQ39887680-AFE976B0-B32D-42AC-A311-7ABF18F45B79Q40211421-215C990D-6837-41A9-8B3A-A9E67E66663BQ40403868-F8B50825-EC45-466B-972C-E2DD874F705AQ41422386-81BB026A-C70F-4437-B57F-9B4E164C6A97Q43099617-F382FE6D-CA55-4ADF-86E0-5EECFD52AC0AQ43111345-4A951F5F-5AF7-4F26-A82E-F49E4E3B5863Q44336990-1CAF0DEC-FCF5-4AE8-A877-6C17D75CCA71Q47977698-0F8AE893-A18C-4DD7-B96B-837C5DF0B07C
P2860
Analgesic and antiinflammatory effects of two novel kappa-opioid peptides.
description
2001 nî lūn-bûn
@nan
2001 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Analgesic and antiinflammatory effects of two novel kappa-opioid peptides.
@ast
Analgesic and antiinflammatory effects of two novel kappa-opioid peptides.
@en
Analgesic and antiinflammatory effects of two novel kappa-opioid peptides.
@nl
type
label
Analgesic and antiinflammatory effects of two novel kappa-opioid peptides.
@ast
Analgesic and antiinflammatory effects of two novel kappa-opioid peptides.
@en
Analgesic and antiinflammatory effects of two novel kappa-opioid peptides.
@nl
prefLabel
Analgesic and antiinflammatory effects of two novel kappa-opioid peptides.
@ast
Analgesic and antiinflammatory effects of two novel kappa-opioid peptides.
@en
Analgesic and antiinflammatory effects of two novel kappa-opioid peptides.
@nl
P2093
P1433
P1476
Analgesic and antiinflammatory effects of two novel kappa-opioid peptides.
@en
P2093
J L Junien
P J Rivière
P304
P356
10.1097/00000542-200106000-00018
P407
P577
2001-06-01T00:00:00Z